Vanguard Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432M | Buy |
|
|||||
|
2025
Q1 | $439M | Sell |
|
|||||
|
2024
Q4 | $414M | Buy |
|
|||||
|
2024
Q3 | $339M | Buy |
|
|||||
|
2024
Q2 | $274M | Sell |
|
|||||
|
2024
Q1 | $273M | Buy |
|
|||||
|
2023
Q4 | $243M | Buy |
|
|||||
|
2023
Q3 | $178M | Buy |
|
|||||
|
2023
Q2 | $307M | Sell |
|
|||||
|
2023
Q1 | $368M | Buy |
|
|||||
|
2022
Q4 | $280M | Buy |
|
|||||
|
2022
Q3 | $362M | Buy |
|
|||||
|
2022
Q2 | $288M | Buy |
|
|||||
|
2022
Q1 | $259M | Buy |
|
|||||
|
2021
Q4 | $274M | Buy |
|
|||||
|
2021
Q3 | $251M | Buy |
|
|||||
|
2021
Q2 | $285M | Buy |
|
|||||
|
2021
Q1 | $303M | Buy |
|
|||||
|
2020
Q4 | $378M | Buy |
|
|||||
|
2020
Q3 | $272M | Buy |
|
|||||
|
2020
Q2 | $288M | Buy |
|
|||||
|
2020
Q1 | $249M | Buy |
|
|||||
|
2019
Q4 | $261M | Buy |
|
|||||
|
2019
Q3 | $175M | Buy |
|
|||||
|
2019
Q2 | $228M | Buy |
|
|||||
|
2019
Q1 | $187M | Buy |
|
|||||
|
2018
Q4 | $158M | Buy |
|
|||||
|
2018
Q3 | $210M | Buy |
|
|||||
|
2018
Q2 | $108M | Buy |
|
|||||
|
2018
Q1 | $80.1M | Buy |
|
|||||
|
2017
Q4 | $46.3M | Sell |
|
|||||
|
2017
Q3 | $58.7M | Buy |
|
|||||
|
2017
Q2 | $43.4M | Buy |
|
|||||
|
2017
Q1 | $19.9M | Buy |
|
|||||
|
2016
Q4 | $20.9M | Buy |
|
|||||
|
2016
Q3 | $25.9M | Sell |
|
|||||
|
2016
Q2 | $16.4M | Buy |
|
|||||
|
2016
Q1 | $13.3M | Buy |
|
|||||
|
2015
Q4 | $66.3M | Buy |
|
|||||
|
2015
Q3 | $53.2M | Buy |
|
|||||
|
2015
Q2 | $82.8M | Buy |
|
|||||
|
2015
Q1 | $99.2M | Buy |
|
|||||
|
2014
Q4 | $60.8M | Buy |
|
|||||
|
2014
Q3 | $24.9M | Buy |
|
|||||
|
2014
Q2 | $14.3M | Buy |
|
|||||
|
2014
Q1 | $12.2M | Buy |
|
|||||
|
2013
Q4 | $2.5M | Buy |
|
|||||
|
2013
Q3 | $1.18M | Buy |
|